Clinical Trial Update: Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast [EARLY_Phase 1]

View source ↗

Summary

Early-phase (Phase 1) clinical trial evaluating the radiotracer Anti-[18F]FACBC for PET-CT imaging in breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anti-[18F]FACBC (Anti-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid)

Snippet

Sponsor: Emory University | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED